- Investing Ideas
- Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Polish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
3
0 new
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Ryvu Therapeutics
Market Cap: zł320.0m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł13.84
7D
-3.2%
1Y
-56.3%
Molecure
Market Cap: zł115.2m
A biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland.
MOC
zł5.59
7D
-1.4%
1Y
5.7%
Poltreg
Market Cap: zł112.4m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł19.00
7D
1.6%
1Y
-38.3%